Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Coinbase Global, Inc. (COIN) vs Revvity Inc (RVTY) Price & Performance

Coinbase Global, Inc.Trade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

Coinbase Global, Inc. vs Revvity Inc — how do they compare? Coinbase Global, Inc. trades at $179.39 (market cap $45.38B), while Revvity Inc trades at $154.18 (market cap $16.98B). The key difference: Coinbase Global, Inc. is far larger — about 2.7× Revvity Inc's market cap, and Revvity Inc pays a 0.18% dividend while Coinbase Global, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Coinbase Global, Inc. for 78 Days and Revvity Inc for 12 Days on average.

COINRVTY
Market Cap
$45.38B$16.98B
Volume
11,013,9401,456,900
Sector
FinancialsHealth
52-Week High
$361.43$157.36
52-Week Low
$141.09$82.26
Typical Hold Time
78 Days12 Days
Enterprise Value
$43.03B$19.30B
Dividend Yield
—0.18%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Coinbase Global, Inc.

Coinbase Global (COIN) trades at $172.00, down 3.61% on the day, reflecting recent volatility amid mixed earnings results. The stock's technical picture shows a bearish moving average trend but oversold RSI readings, with key support at $170. Fundamentally, 2025 revenue grew to $7.18 billion with $1.26 billion net income, though 2026 projections indicate a potential net loss. Analyst sentiment remains predominantly bullish with a $212.36 consensus price target, supported by recent CFTC approval for derivatives expansion and deepened banking partnerships.

The outlook for COIN hinges on reversing 2026 earnings misses and leveraging regulatory approvals for derivatives and stablecoin partnerships. Investment opportunity exists if the company returns to profitability and capitalizes on institutional crypto adoption, but risks include sustained negative earnings, competitive pressures, and crypto market volatility. Wall Street's buy-rated consensus suggests confidence in long-term execution despite near-term headwinds.

Revvity Inc

RVTY trades at $152.16, down 0.94% on the day, but maintains a bullish technical trend with strong moving average signals and support near $149. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results expected soon. Revenue remains stable around $2.9 billion, though net income margins have softened slightly. Recent news highlights product launches and strategic acquisitions, such as the Human Cell Design deal, to bolster its life sciences portfolio.

The outlook is supported by analyst optimism with a 51.72% buy rating and a consensus price target of $132.13, though the current price trades above this target. Key risks include premium valuation metrics, margin pressures, and exposure to macroeconomic headwinds. The stock's proximity to its 52-week high suggests momentum but warrants caution given rich multiples.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

COIN
56% Buy44% Sell
Avg holding period · 78 Days
RVTY
0% Buy100% Sell
Avg holding period · 12 Days

Top news

Latest headlines on both assets

About Coinbase Global, Inc.

Coinbase Global, Inc. is a regulated cryptocurrency company that provides customers around the world with a platform for buying, selling, transferring, and storing digital assets. The Company offers a variety of products and services that enable individuals, businesses, and developers to participate in the cryptoeconomy.

Read more on COIN →

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY →